FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

420627008: Extended-release tablet (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    2614087016 Extended-release tablet (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    2616687018 Extended-release tablet en Synonym Active Entire term case insensitive SNOMED CT core module
    2660656013 Extended-release tablet (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Extended-release tablet Is a Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Prolonged-release film-coated oral tablet Is a False Extended-release tablet Inferred relationship Existential restriction modifier
    Gastro-resistant and prolonged-release oral tablet Is a False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely paliperidone 9 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely paliperidone 6 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely paliperidone 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Amoxicillin 775mg extended release tablet Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely quetiapine (as quetiapine fumarate) 300 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely quetiapine (as quetiapine fumarate) 200 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely zileuton 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely bupropion hydrobromide 348 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely bupropion hydrobromide 174 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Guanfacine hydrochloride 4mg extended release tablet Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Guanfacine hydrochloride 3mg extended release tablet Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Guanfacine hydrochloride 1mg extended release tablet Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely nicotinic acid 250 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely ropinirole (as ropinirole hydrochloride) 8 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Guanfacine hydrochloride 2mg extended release tablet Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely ropinirole (as ropinirole hydrochloride) 4 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Ropinirole 3mg extended release tablet Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely levetiracetam 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely bupropion hydrobromide 522 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely potassium chloride 1.5 gram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely pramipexole dihydrochloride 375 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely pramipexole dihydrochloride 750 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely pramipexole dihydrochloride 1.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely trazodone hydrochloride 300 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely trazodone hydrochloride 150 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely fampridine 10 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely pramipexole dihydrochloride 4.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely pramipexole dihydrochloride 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely nevirapine 400 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Seroquel XL 200mg tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Seroquel XL 300mg tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Seroquel XL 400mg tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Seroquel XL 200mg tablets (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Seroquel XL 300mg tablets (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Seroquel XL 400mg tablets (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Sondate XL 200mg tablets (Teva UK Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Sondate XL 300mg tablets (Teva UK Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Sondate XL 400mg tablets (Teva UK Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Tenprolide XL 200mg tablets (Actavis UK Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Tenprolide XL 300mg tablets (Actavis UK Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Seotiapim XL 200mg tablets (Sandoz Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Seotiapim XL 400mg tablets (Sandoz Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Seotiapim XL 300mg tablets (Sandoz Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Tenprolide XL 400mg tablets (Actavis UK Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Ebesque XL 200mg tablets (DB Ashbourne Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Ebesque XL 300mg tablets (DB Ashbourne Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Ebesque XL 400mg tablets (DB Ashbourne Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Atrolak XL 200mg tablets (Accord Healthcare Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Atrolak XL 300mg tablets (Accord Healthcare Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Atrolak XL 400mg tablets (Accord Healthcare Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Biquelle XL 300mg tablets (Aspire Pharma Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Biquelle XL 400mg tablets (Aspire Pharma Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Biquelle XL 200mg tablets (Aspire Pharma Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Zaluron XL 200mg tablets (Fontus Health Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Zaluron XL 300mg tablets (Fontus Health Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Zaluron XL 400mg tablets (Fontus Health Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Mintreleq XL 200mg tablets (CEB Pharma Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Mintreleq XL 300mg tablets (CEB Pharma Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Mintreleq XL 400mg tablets (CEB Pharma Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Psyquet XL 200mg tablets (Sandoz Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Psyquet XL 300mg tablets (Sandoz Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Psyquet XL 400mg tablets (Sandoz Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Nevirapine 400mg modified-release tablets (Teva UK Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Nevirapine 400mg modified-release tablets (A A H Pharmaceuticals Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Brancico XL 300mg tablets (Zentiva Pharma UK Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Brancico XL 200mg tablets (Zentiva Pharma UK Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Brancico XL 400mg tablets (Zentiva Pharma UK Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier
    Nevirapine 400mg modified-release tablets (Viatris UK Healthcare Ltd) Has manufactured dose form False Extended-release tablet Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start